The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Molecular abnormalities of 17 types of gastrointestinal cancer in an international cohort of 11,324 patients.
Gargi Dan Basu
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
Zoran Gatalica
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
Sherri Z. Millis
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
Fadi S. Braiteh
Consultant or Advisory Role - Caris Life Sciences